BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 4880118)

  • 1. Propranolol in the office treatment of angina pectoris.
    Harley BJ; Davies RO
    Can Med Assoc J; 1968 Sep; 99(11):527-30. PubMed ID: 4880118
    [No Abstract]   [Full Text] [Related]  

  • 2. A double blind study of Visken LB-46, in the treatment of angina pectoris.
    Nair DV
    Indian Heart J; 1972 Jun; 24():Suppl 1:183-91. PubMed ID: 4581426
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy of angina pectoris with propranolol and long-acting nitrates.
    Goldbarg AN; Morgan JF; Butterfield TK; Nemickas R; Bermudez GA
    Circulation; 1969 Dec; 40(6):847-53. PubMed ID: 4990005
    [No Abstract]   [Full Text] [Related]  

  • 4. A double blind drug trial of LB-46 (visken) in angina pectoris.
    Sainani GS; Mukherjee AK
    Indian Heart J; 1972 Jun; 24():Suppl 1:192-6. PubMed ID: 4581427
    [No Abstract]   [Full Text] [Related]  

  • 5. Propranolol and LB 46 (prinodolol) in angina pectoris. A comparative long-term ergometric study.
    Arstila M; Kallio V; Wendelin H
    Ann Clin Res; 1973 Apr; 5(2):91-100. PubMed ID: 4201295
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy of angina pectoris with propranolol and long-acting nitrates.
    Goldbarg AN; Moran JF; Butterfield TK; Nemickas R; Bermudez GA
    Circulation; 1969 Dec; 40(6):847-53. PubMed ID: 4988122
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of two adrenergic beta-receptor blocking agents, alprenolol and propranolol, in treatment of angina pectoris.
    Heterington DJ; Comerford MB; Nyberg G; Besterman EM
    Br Heart J; 1973 Mar; 35(3):320-33. PubMed ID: 4632566
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of propranolol in angina pectoris. Clinical dose response curve and effect on electrocardiogram at rest and on exercise.
    Prichard BN; Gillam PM
    Br Heart J; 1971 Jul; 33(4):473-80. PubMed ID: 4997528
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of angina pectoris with molsidomin: results of a double-blind study for assessment of rate of anginal attacks, exercise reaction, and systolic time intervals (author's transl)].
    Mannes GA; Goebel G; Kafka W; Rudolph W
    Herz; 1978 Jun; 3(3):172-84. PubMed ID: 363584
    [No Abstract]   [Full Text] [Related]  

  • 10. Double blind cross-over clinical trial of acebutolol and propranolol in angina pectoris.
    Pandhi P; Sethi V; Sharma BK; Wahi PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):598-600. PubMed ID: 3908331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new beta adrenergic blocking agent, propranolol, in the treatment of angina pectoris.
    Hebb AR; Godwin TF; Gunn RW
    Can Med Assoc J; 1968 Feb; 98(5):246-51. PubMed ID: 4965821
    [No Abstract]   [Full Text] [Related]  

  • 12. [Double-blind studies with Inderal in angina pectoris].
    Moser K; Lujf A
    Wien Klin Wochenschr; 1967 May; 79(18):349-52. PubMed ID: 4869793
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical effect of oxprenolol in angina pectoris: comparison with a placebo and propranolol by double blind assay].
    Murakami M; Murakami E; Takekoshi J; Hayase S; Shintani H
    Nihon Rinsho; 1973 Apr; 31(4):913-22. PubMed ID: 4580401
    [No Abstract]   [Full Text] [Related]  

  • 14. Propranolol in angina pectoris.
    Zsotér TT; Beanlands DS
    Arch Intern Med; 1969 Nov; 124(5):584-7. PubMed ID: 4981284
    [No Abstract]   [Full Text] [Related]  

  • 15. Propranolol in the therapy of ischaemic heart disease with angina pectoris.
    Banerjea JC; Mukherjee SK; Mukherjee TP
    Indian Heart J; 1969 Jul; 21(3):259-72. PubMed ID: 4904075
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical trial of oxyfedrine and propranolol in angina pectoris].
    Chaĭtington DzhR ; Refteri EB
    Ter Arkh; 1980; 52(5):59-62. PubMed ID: 6996188
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inderal in angina pectoris].
    Fitzgerald JD
    Wien Klin Wochenschr; 1967 May; 79(18):332-6. PubMed ID: 4384816
    [No Abstract]   [Full Text] [Related]  

  • 18. Superiority of verapamil to propranolol in stable angina pectoris: a double-blind, randomized crossover trail.
    Frishman WH; Klein NA; Strom JA; Willens H; LeJemtel TH; Jentzer J; Siegel L; Klein P; Kirschen N; Silverman R; Pollack S; Doyle R; Kirsten E; Sonnenblick EH
    Circulation; 1982 Jan; 65(1 Pt 2):I51-9. PubMed ID: 6796289
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of tolamolol versus propranolol on systolic time intervals in angina.
    Aronow WS; Vawter M; Spivack N; Warren M; Laverty W
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1069-76. PubMed ID: 4154826
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of propranolol and alprenolol in angina pectoris--a double blind study].
    Sakakibara H; Matsutani K; Mochizuki S; Kitabatake S; Takagishi S
    Jpn Circ J; 1970 Apr; 34(4):319-33. PubMed ID: 4996004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.